AC Immune ACIU
NASDAQ ACIU
$2.60 -0.01 (-0.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

AC Immune (ACIU) Share-based Compensation (2015 - 2025)

Updated

AC Immune (ACIU) recorded Share-based Compensation of $1.13 million in the quarter ended Dec 31, 2025, up 2.5% from $1.1 million a year earlier and up 11.3% from the prior quarter.

Analysis

AC Immune (ACIU) Share-based Compensation (2015 - 2025) Analysis & Trends

For the year ended Dec 31, 2025, AC Immune reported Share-based Compensation of $5.3 million, down 14.7% from the prior year.

  • Annual Share-based Compensation has a five-year compound annual growth rate of 4.0% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Share-based Compensation came in at $6.22 million in the year ended Dec 31, 2024 (+27.9%), $4.86 million in the year ended Dec 31, 2023 (+39.2%), $3.49 million in the year ended Dec 31, 2022 (-22.7%) and $4.52 million in the year ended Dec 31, 2021 (+3.6%).
  • Quarterly Share-based Compensation has ranged from $574,678 in the quarter ended Sep 30, 2022 to $2.16 million in the quarter ended Mar 31, 2024 over the past five years.
  • On a year-over-year basis, Share-based Compensation rose in five of the last eight quarters, with growth averaging 7.2%.
  • Peak year-over-year performance for Share-based Compensation in the last five years was growth of 70.8% in the quarter ended Sep 30, 2023, against a decline of 62.0% in the quarter ended Sep 30, 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.02 million (quarter ended Sep 30, 2025), $1.35 million (quarter ended Jun 30, 2025) and $1.73 million (quarter ended Mar 31, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 AC Immune 265.55 Mn 265.55 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.13 Mn
Sep 30, 2025 1.02 Mn
Jun 30, 2025 1.35 Mn
Mar 31, 2025 1.73 Mn
Dec 31, 2024 1.10 Mn
Sep 30, 2024 1.42 Mn
Jun 30, 2024 1.54 Mn
Mar 31, 2024 2.16 Mn
Dec 31, 2023 898,501.52
Sep 30, 2023 981,576.27
Jun 30, 2023 1.37 Mn
Mar 31, 2023 1.59 Mn
Dec 31, 2022 922,801.48
Sep 30, 2022 574,678.43
Jun 30, 2022 932,387.12
Mar 31, 2022 1.07 Mn
Dec 31, 2021 1.13 Mn
Sep 30, 2021 1.51 Mn
Jun 30, 2021 916,796.99
Mar 31, 2021 947,892.62
API Access

AC Immune Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ACIU&period=max&api_key=YOUR_API_KEY